Free Trial
NASDAQ:BKYI

BIO-key International Q2 2025 Earnings Report

BIO-key International logo
$0.84 +0.02 (+2.19%)
As of 03:52 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BIO-key International EPS Results

Actual EPS
N/A
Consensus EPS
-$0.15
Beat/Miss
N/A
One Year Ago EPS
N/A

BIO-key International Revenue Results

Actual Revenue
N/A
Expected Revenue
$1.70 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

BIO-key International Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Thursday, August 14, 2025
Conference Call Time
10:00AM ET

Conference Call Resources

BIO-key International Earnings Headlines

BIO-key International, Inc. (BKYI) - Yahoo Finance
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
See More BIO-key International Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BIO-key International? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BIO-key International and other key companies, straight to your email.

About BIO-key International

BIO-key International (NASDAQ:BKYI), Inc. (NASDAQ: BKYI) is a provider of biometric identity management and multi‐factor authentication solutions designed to secure access to digital resources. The company’s core business revolves around the development, marketing and support of fingerprint recognition hardware and software, as well as cloud‐based and on‐premise identity and access management (IAM) platforms. BIO-key’s suite of products enables organizations to replace or supplement traditional password systems with more secure, user‐friendly biometric authentication methods.

The company’s flagship offerings include biometric readers, software development kits (SDKs) and PortalGuard, a comprehensive IAM solution that integrates single sign‐on, multi‐factor authentication and self‐service credential management. BIO-key’s fingerprint readers are FIPS 201‐compliant and cater to enterprise IT, healthcare, government and financial services customers. Its cloud‐native and on‐premises deployment models provide flexibility, enabling clients to implement biometric security without overhauling existing infrastructure.

Founded in 1996 and headquartered in Farmingdale, New York, BIO-key International has expanded its reach through strategic partnerships and distribution agreements across North America, Europe and the Asia‐Pacific region. Over its history, the company merged with various technology firms to bolster its product portfolio and broaden its addressable market. Its publicly traded status since 2005 has supported ongoing investments in research and development, with a focus on mobile biometric applications and next‐generation authentication techniques.

Under the leadership of President and Chief Executive Officer Michael DePasquale IV, BIO-key has pursued growth through innovation and targeted acquisitions. Management emphasizes compliance with industry security standards and the delivery of scalable solutions that reduce password‐related help‐desk costs and strengthen overall cybersecurity posture. As demand for stronger identity verification intensifies, BIO-key continues to position itself as a specialist in frictionless, biometric‐first authentication technologies.

View BIO-key International Profile

More Earnings Resources from MarketBeat